Subsidiary of Shandong Xinhua Pharmaceutical (000756.SZ) obtained the registration certificate for ibuprofen granules.
Xinhua Pharmaceutical (000756.SZ) announced that its wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical Co., Ltd. (referred to as "Xinda Pharmaceutical") has received the "Drug Registration Certificate" for ibuprofen granules issued by the National Medical Products Administration.
Shandong Xinhua Pharmaceutical (000756.SZ) announced that its wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical Co., Ltd. (referred to as "Xinda Pharmaceutical") has received the Drug Registration Certificate for Ibuprofen Granules issued by the State Food and Drug Administration.
Related Articles
Dongjiang Environmental (00895): "25 Dongjiang Environmental MTN001" will pay interest on March 28th.
G-RESOURCES (01051) is pleased to announce that the expected net profit for the year 2025 is approximately 97 million US dollars, representing a year-on-year increase.
CQRC BANK (03618): Tang Bin's qualification as the Secretary of the Board of Directors has been approved.
Dongjiang Environmental (00895): "25 Dongjiang Environmental MTN001" will pay interest on March 28th.
G-RESOURCES (01051) is pleased to announce that the expected net profit for the year 2025 is approximately 97 million US dollars, representing a year-on-year increase.
CQRC BANK (03618): Tang Bin's qualification as the Secretary of the Board of Directors has been approved.
